154 related articles for article (PubMed ID: 34845977)
1.
Fagerholm U; Hellberg S; Alvarsson J; Arvidsson McShane S; Spjuth O
Xenobiotica; 2021 Dec; 51(12):1366-1371. PubMed ID: 34845977
[TBL] [Abstract][Full Text] [Related]
2. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
[TBL] [Abstract][Full Text] [Related]
3. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?
Caldwell GW; Masucci JA; Yan Z; Hageman W
Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342
[TBL] [Abstract][Full Text] [Related]
4. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Tissue to Plasma Concentration Ratios of Drugs in the Rat from Experimentally Estimated Volume of Distribution: Application of Allometry.
Mahmood I
Curr Drug Metab; 2018; 19(2):155-164. PubMed ID: 29189141
[TBL] [Abstract][Full Text] [Related]
6. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
[TBL] [Abstract][Full Text] [Related]
7.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
Altern Lab Anim; 2023 Jan; 51(1):39-54. PubMed ID: 36572567
[TBL] [Abstract][Full Text] [Related]
8. In silico human and rat Vss quantitative structure-activity relationship models.
Gleeson MP; Waters NJ; Paine SW; Davis AM
J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
[TBL] [Abstract][Full Text] [Related]
9. In Silico Models of Human PK Parameters. Prediction of Volume of Distribution Using an Extensive Data Set and a Reduced Number of Parameters.
Lombardo F; Bentzien J; Berellini G; Muegge I
J Pharm Sci; 2021 Jan; 110(1):500-509. PubMed ID: 32891631
[TBL] [Abstract][Full Text] [Related]
10.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
Xenobiotica; 2022 Feb; 52(2):113-118. PubMed ID: 35238270
[TBL] [Abstract][Full Text] [Related]
11. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
[TBL] [Abstract][Full Text] [Related]
12. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling.
De Sutter PJ; Rossignol P; Breëns L; Gasthuys E; Vermeulen A
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765316
[TBL] [Abstract][Full Text] [Related]
13. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics.
Sayama H; Komura H; Kogayu M; Iwaki M
J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828
[TBL] [Abstract][Full Text] [Related]
14. Computational Predictions of Nonclinical Pharmacokinetics at the Drug Design Stage.
Stoyanova R; Katzberger PM; Komissarov L; Khadhraoui A; Sach-Peltason L; Groebke Zbinden K; Schindler T; Manevski N
J Chem Inf Model; 2023 Jan; 63(2):442-458. PubMed ID: 36595708
[TBL] [Abstract][Full Text] [Related]
15. Application of the Tissue Composition-Based Model to Minipig for Predicting the Volume of Distribution at Steady State and Dermis-to-Plasma Partition Coefficients of Drugs Used in the Physiologically Based Pharmacokinetics Model in Dermatology.
Poulin P; Collet SH; Atrux-Tallau N; Linget JM; Hennequin L; Wilson CE
J Pharm Sci; 2019 Jan; 108(1):603-619. PubMed ID: 30222978
[TBL] [Abstract][Full Text] [Related]
16. Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds.
Parrott N; Manevski N; Olivares-Morales A
Mol Pharm; 2022 Nov; 19(11):3858-3868. PubMed ID: 36150125
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
18. A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral Drugs.
Poulin P; Nicolas JM; Bouzom F
J Pharm Sci; 2024 Jan; 113(1):118-130. PubMed ID: 37634869
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Prediction Accuracy for Volume of Distribution in Rat and Human Using In Vitro, In Vivo, PBPK and QSAR Methods.
Mathew S; Tess D; Burchett W; Chang G; Woody N; Keefer C; Orozco C; Lin J; Jordan S; Yamazaki S; Jones R; Di L
J Pharm Sci; 2021 Apr; 110(4):1799-1823. PubMed ID: 33338491
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
Kosugi Y; Hosea N
Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
